AUSTEDO® significantly reduced Huntington's disease chorea vs placebo1

Self-reported HD symptom improvement

Overall HD symptoms were rated as “much improved” or “very much improved” with AUSTEDO® vs placebo. People taking AUSTEDO® also reported being less limited in performing daily activities.1,2

%
TAKING AUSTEDO®
vs
%
TAKING PLACEBO
AUSTEDO®(deutetrabenazine) tablets improved HD Symptoms 51% of Participants Rated Symptoms as Improved with AUSTEDO® (deutetrabenazine) tablets vs. 20% Taking Placebo placebo AUSTEDO ®

51% of people taking AUSTEDO®
reported that their overall HD symptoms were “much improved” or “very much improved” at the end of treatment, compared with 20% of those taking placebo.1

%
TAKING AUSTEDO®
vs
%
TAKING PLACEBO
AUSTEDO®(deutetrabenazine) tablets improved HD Symptoms 42% of Doctors Rated People Symptoms as Improved with AUSTEDO®(deutetrabenazine) tablets vs. 13% Taking Placebo placebo AUSTEDO ®

42% of doctors treating people taking AUSTEDO® reported that overall HD symptoms observed were “much improved” or “very much improved” at the end of treatment, compared with 13% treating participants taking placebo.1

AUSTEDO® is a medicine to treat HD chorea. It does not treat other symptoms of HD, such as problems with thinking or emotions.

Download the Doctor Discussion Guide

This resource can help you and your doctor decide if AUSTEDO® is right for you.

You are about to leave this site

You are about to leave AUSTEDO.com and enter a website operated by a third party. Teva is not responsible for and does not control the content contained on this third-party website linked to AUSTEDO.com.

Are you a healthcare professional?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?

References: 1. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc. 2. Data on file. Teva Neuroscience, Inc.